Debio-025, a cyclophilin inhibitor, has been shown to improve muscle pathology associated with several mouse models of muscular dystrophy, including Sgcd-/- mice, through its action of preventing MPTP-induced myofiber necrosis [11,17]. Here, SGCD is linked to muscular dystrophy.